The First Hospital of Jilin University
π¨π³China
- Country
- π¨π³China
- Ownership
- -
- Established
- 1920-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.bethune-jilin.cn
Hypofractionated Radiotherapy
Not Applicable
Recruiting
- Conditions
- First Posted Date
- 2024-12-18
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- The First Hospital of Jilin University
- Target Recruit Count
- 420
- Registration Number
- NCT06740955
- Locations
- π¨π³
The First Hospital of Jilin University, Changchun, Jilin, China
Effect of Gut Microbiota and Its Metabolites on the Efficacy of Immunotherapy in Metastatic Colorectal Cancer
Recruiting
- Conditions
- First Posted Date
- 2024-12-04
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- The First Hospital of Jilin University
- Target Recruit Count
- 50
- Registration Number
- NCT06714903
- Locations
- π¨π³
The First Hospital of Jilin University, Changchun, Jilin, China
Clinical Trial of Eribulin in Combination with Anrotinib for HER-2 Negative Locally Advanced or Metastatic Breast Cancer
- First Posted Date
- 2024-11-07
- Last Posted Date
- 2024-11-07
- Lead Sponsor
- The First Hospital of Jilin University
- Target Recruit Count
- 40
- Registration Number
- NCT06678230
- Locations
- π¨π³
Cancer Center, The First Affiliated Hospital of Jilin University, Changchun, Jilin Province, China, Changchun, Jilin, China
Study on the Efficacy and Safety of Thermotherapy in the Treatment of Refractory Gout
Not Applicable
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-10-22
- Last Posted Date
- 2024-10-22
- Lead Sponsor
- The First Hospital of Jilin University
- Target Recruit Count
- 128
- Registration Number
- NCT06653686
Preliminary Study of CXCL3 As a Biomarker of Diabetic Kidney Disease
Not Applicable
Completed
- Conditions
- First Posted Date
- 2024-10-14
- Last Posted Date
- 2024-10-14
- Lead Sponsor
- The First Hospital of Jilin University
- Target Recruit Count
- 120
- Registration Number
- NCT06639529
- Locations
- π¨π³
The First Hospital of Jilin University, Changchun, Jilin, China
A Prospective Cohort of Patients With Cervical/Intracranial Arteries Stenosis in China
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-10-03
- Lead Sponsor
- The First Hospital of Jilin University
- Target Recruit Count
- 60000
- Registration Number
- NCT06595342
- Locations
- π¨π³
First Hospital of Jilin University, Changchun, Jilin, China
Linperlisib Combination With Obinutuzumab Frontline Treatment of Marginal Zone Lymphoma Patients (MZL)
- First Posted Date
- 2024-09-11
- Last Posted Date
- 2024-09-11
- Lead Sponsor
- The First Hospital of Jilin University
- Target Recruit Count
- 35
- Registration Number
- NCT06592170
- Locations
- π¨π³
The First Hospital of Jilin University, Changchun, Jilin, China
Cardenilimab Combined With Lenvatinib in Patients With Perioperative Resectable Clear Cell Renal Cell Carcinoma.
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-08-28
- Last Posted Date
- 2024-08-28
- Lead Sponsor
- The First Hospital of Jilin University
- Target Recruit Count
- 30
- Registration Number
- NCT06574412
A Clinical Study Assessing the Efficacy of Chidamide for CD30-positive Peripheral T-cell Lymphoma (PTCL).
- First Posted Date
- 2024-08-13
- Last Posted Date
- 2024-08-29
- Lead Sponsor
- The First Hospital of Jilin University
- Target Recruit Count
- 35
- Registration Number
- NCT06550336
- Locations
- π¨π³
The First Bethune Hospital of Jilin University, Changchun, Jilin, China
Effect of HIPEC After Radical Surgery on Long-term Survival for Locally Advanced Gastric Cancer
Early Phase 1
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-07-29
- Last Posted Date
- 2024-07-31
- Lead Sponsor
- The First Hospital of Jilin University
- Target Recruit Count
- 302
- Registration Number
- NCT06525714
Β© Copyright 2024. All Rights Reserved by MedPath